ONE Bio, Corp. ("ONE" or the "Company") (OTCBB:ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary Green Planet Bioengineering, Co., Ltd. ("CHE") filed a patent covering its newly developed extraction process for Salvia Miltiorrhiza (aka as "Danshen").

The new Salvia Miltiorrhiza extract is expected to contribute approximately $2.2 million to the Company's revenue for the remaining of this year with several placed orders pending delivery. The extract is expected to boost the Company's CHE division revenues which has already gained co-operative contracts with multiple renowned pharmaceuticals including Heji Huangpu Baiyunshan Pharmaceutical, Beijing Tongrentang Pharmaceutical, Guangdong Medihealth Pharmaceutical and Jiangmen Mingsheng Pharmaceutical.

The CHE division successfully developed and obtained the Salvia extraction patent in June 2010 referred to as "Sync effective extraction process." In the process the CHE division uses a sophisticated technology to break Salvia roots to achieve a 97% transfer rate for both Tanshinone ¿ A and danshinolic acid B. The 97% transfer rate achieved is 30% higher than the traditional extraction process.

"We are pleased to have obtained this important patent which has allowed us to launch this highly demanded Salvia extract. Initial sales for the extract are very encouraging. Our R&D team continues to deliver us an increasing product portfolio highly demanded in the market place," states ONE's CEO Mr. Marius Silvasan.